{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "21689010", "DateCompleted": {"Year": "2011", "Month": "10", "Day": "11"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.3109/08958378.2011.584919"], "ArticleDate": [], "Journal": {"ISSN": "1091-7691", "JournalIssue": {"Volume": "23", "Issue": "8", "PubDate": {"Year": "2011", "Month": "Jul"}}, "Title": "Inhalation toxicology", "ISOAbbreviation": "Inhal Toxicol"}, "ArticleTitle": "Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice.", "Pagination": {"StartPage": "486", "EndPage": "494", "MedlinePgn": "486-94"}, "Abstract": {"AbstractText": ["Ozone (O\u2083), a commonly encountered environmental pollutant, has been shown to induce pulmonary fibrosis in different animal models; the underlying mechanism, however, remains elusive. To investigate the molecular mechanism underlying O\u2083-induced pulmonary fibrosis, 6- to 8-week-old C57BL/6 male mice were exposed to a cyclic O\u2083 exposure protocol consisting of 2 days of filtered air and 5 days of O\u2083 exposure (0.5 ppm, 8 h/day) for 5 and 10 cycles with or without intraperitoneal injection of IN-1233, a specific inhibitor of the type 1 receptor of transforming growth factor beta (TGF-\u03b2), the most potent profibrogenic cytokine. The results showed that O\u2083 exposure for 5 or 10 cycles increased the TGF-\u03b2 protein level in the epithelial lining fluid (ELF), associated with an increase in the expression of plasminogen activator inhibitor 1 (PAI-1), a TGF-\u03b2-responsive gene that plays a critical role in the development of fibrosis under various pathological conditions. Cyclic O\u2083 exposure also increased the deposition of collagens and alpha smooth muscle actin (\u03b1-SMA) in airway walls. However, these fibrotic changes were not overt until after 10 cycles of O\u2083 exposure. Importantly, blockage of the TGF-\u03b2 signaling pathway with IN-1233 suppressed O\u2083-induced Smad2/3 phosphorylation, PAI-1 expression, as well as collagens and \u03b1-SMA deposition in the lung. Our data demonstrate for the first time that O\u2083 exposure increases TGF-\u03b2 expression and activates TGF-\u03b2 signaling pathways, which mediates O\u2083-induced lung fibrotic responses in vivo."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA."}], "Identifier": [], "LastName": "Katre", "ForeName": "Ashwini", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ballinger", "ForeName": "Carol", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Akhter", "ForeName": "Hasina", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fanucchi", "ForeName": "Michelle", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kim", "ForeName": "Dae-Kee", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Postlethwait", "ForeName": "Edward", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Rui-Ming", "Initials": "RM"}], "GrantList": [{"GrantID": "P01 ES011617", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL054696", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES011831", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL54696", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL088141", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Inhal Toxicol", "NlmUniqueID": "8910739", "ISSNLinking": "0895-8378"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "3-((4-(6-methylpyridin-2-yl)-5-(quinolin-6-yl)-1H-imidazol-2-yl)methyl)benzamide"}, {"RegistryNumber": "0", "NameOfSubstance": "Actins"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzamides"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Serpin E2"}, {"RegistryNumber": "0", "NameOfSubstance": "Serpine2 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad2 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad2 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad3 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9007-34-5", "NameOfSubstance": "Collagen"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Actins"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzamides"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Bronchi"}, {"QualifierName": ["metabolism"], "DescriptorName": "Collagen"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Inhalation Exposure"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Pulmonary Fibrosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinolines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serpin E2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Smad2 Protein"}, {"QualifierName": ["metabolism"], "DescriptorName": "Smad3 Protein"}, {"QualifierName": ["analysis", "antagonists & inhibitors", "metabolism"], "DescriptorName": "Transforming Growth Factor beta1"}], "CoiStatement": "<b>Declaration of interest</b>. The work was supported by grants from National Institute of Environmental Health Sciences R01 ES011831 (RML) and P01 ES011617 (EMP, MF, and CB), National Heart, Lung, and Blood Institute R01 HL088141 (RML) and R01 HL54696 (EMP), and the American Lung Association (RML)."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol Res Pract. 1994;190:825\u2013833.", "ArticleIdList": ["7899131"]}, {"Citation": "Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, Cadranel J, Baud L. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol. 1999;21:128\u2013136.", "ArticleIdList": ["10385601"]}, {"Citation": "Bergeron A, Soler P, Kambouchne M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J. 2003;22:69\u201376.", "ArticleIdList": ["12882453"]}, {"Citation": "Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA., Jr Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med. 1990;322:890\u2013897.", "ArticleIdList": ["2314423"]}, {"Citation": "Bocci V, Luzzi E, Corradeschi F, Silvestri S. Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment. J Biol Regul Homeost Agents. 1994;8:108\u2013112.", "ArticleIdList": ["7660851"]}, {"Citation": "Bonniaud P, Margetts PJ, Kolb M, Schroeder JA, Kapoun AM, Damm D, Murphy A, Chakravarty S, Dugar S, Higgins L, Protter AA, Gauldie J. Progressive Transforming Growth Factor {beta}1-induced Lung Fibrosis is Blocked by an orally Active ALK5 Kinase Inhibitor. Am J Respir Crit Care Med. 2005;171:889\u2013898.", "ArticleIdList": ["15563636"]}, {"Citation": "Chang LY, Stockstill BL, Menache MG, Mercer RR, Crapo JD. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part VIII: Morphometric analysis of structural alterations in alveolar regions. Res Rep Health Eff Inst. 1995:3\u201339. discussion 99.", "ArticleIdList": ["7619333"]}, {"Citation": "Chuang-Tsai S, Sisson TH, Hattori N, Tsai CG, Subbotina NM, Hanson KE, Simon RH. Reduction in fibrotic tissue formation in mice genetically deficient in plasminogen activator inhibitor-1. Am J Pathol. 2003;163:445\u2013452.", "ArticleIdList": ["PMC1868204", "12875966"]}, {"Citation": "Churg A, Zhou S, Preobrazhenska O, Tai H, Wang R, Wright JL. Expression of Profibrotic Mediators in Small Airways versus Parenchyma after Cigarette Smoke Exposure. Am J Respir Cell Mol Biol. 2009;40:268\u2013276.", "ArticleIdList": ["18723441"]}, {"Citation": "Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol. 1997;150:981\u2013991.", "ArticleIdList": ["PMC1857875", "9060836"]}, {"Citation": "Davidson JM. Biochemistry and turnover of lung interstitium. Eur Respir J. 1990;3:1048\u20131063.", "ArticleIdList": ["2289553"]}, {"Citation": "Dormans JA, van Bree L, Boere AJ, Marra M, Rombout PJ. Interspecies differences in time course of pulmonary toxicity following repeated exposure to ozone. Inhal Toxicol. 1999;11:309\u2013329.", "ArticleIdList": ["10380172"]}, {"Citation": "Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest. 1996;97:232\u2013237.", "ArticleIdList": ["PMC507084", "8550840"]}, {"Citation": "Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, Wewers MD. The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol. 2003;28:499\u2013503.", "ArticleIdList": ["12654639"]}, {"Citation": "Fanucchi MV, Buckpitt AR, Murphy ME, Plopper CG. Naphthalene cytotoxicity of differentiating Clara cells in neonatal mice. Toxicol Appl Pharmacol. 1997;144:96\u2013104.", "ArticleIdList": ["9169074"]}, {"Citation": "Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000a;161:454\u2013462.", "ArticleIdList": ["10673185"]}, {"Citation": "Gunther A, Mosavi P, Ruppert C, Heinemann S, Temmesfeld B, Velcovsky HG, Morr H, Grimminger F, Walmrath D, Seeger W. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Thromb Haemost. 2000b;83:853\u2013860.", "ArticleIdList": ["10896238"]}, {"Citation": "Hattori N, Degen JL, Sisson TH, Liu H, Moore BB, Pandrangi RG, Simon RH, Drew AF. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest. 2000;106:1341\u20131350.", "ArticleIdList": ["PMC381464", "11104787"]}, {"Citation": "Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H, Asano S, Kinoshita M. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol. 2007;83:39\u201346.", "ArticleIdList": ["17274978"]}, {"Citation": "Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest. 1989;84:695\u2013705.", "ArticleIdList": ["PMC548934", "2788176"]}, {"Citation": "Kim JH, Song HY, Park JH, Yoon HJ, Park HG, Kim DK. IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model. Radiology. 2010;255:75\u201382.", "ArticleIdList": ["20308445"]}, {"Citation": "Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of \u201cfibrosis-prone\u201d and \u201cfibrosis-resistant\u201d mouse strains. Am J Respir Cell Mol Biol. 2002;27:141\u2013150.", "ArticleIdList": ["12151305"]}, {"Citation": "Lang DS, Jorres RA, Mucke M, Siegfried W, Magnussen H. Interactions between human bronchoepithelial cells and lung fibroblasts after ozone exposure in vitro. Toxicol Lett. 1998:96\u201397. 13\u201324.", "ArticleIdList": ["9820643"]}, {"Citation": "Last JA, Gelzleichter TR, Harkema J, Hawk S. Consequences of prolonged inhalation of ozone on Fischer-344/N rats: collaborative studies. Part I: Content and cross-linking of lung collagen. Res Rep Health Eff Inst. 1994:1\u201329. discussion 31\u201340.", "ArticleIdList": ["8037892"]}, {"Citation": "Last JA, Hesterberg TW, Reiser KM, Cross CE, Amis TC, Gunn C, Steffey EP, Grandy J, Henrickson R. Ozone-induced alterations in collagen metabolism of monkey lungs: use of biopsy-obtained lung tissue. Toxicol Appl Pharmacol. 1981;60:579\u2013585.", "ArticleIdList": ["7292495"]}, {"Citation": "Last JA, Reiser KM, Tyler WS, Rucker RB. Long-term consequences of exposure to ozone. I. Lung collagen content. Toxicol Appl Pharmacol. 1984;72:111\u2013118.", "ArticleIdList": ["6710477"]}, {"Citation": "Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol. 1987;252:C1\u20139.", "ArticleIdList": ["3544859"]}, {"Citation": "Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, Homer RJ, Elias JA. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med. 2004;200:377\u2013389.", "ArticleIdList": ["PMC2211975", "15289506"]}, {"Citation": "Leonarduzzi G, Scavazza A, Biasi F, Chiarpotto E, Camandola S, Vogel S, Dargel R, Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. Faseb J. 1997;11:851\u2013857.", "ArticleIdList": ["9285483"]}, {"Citation": "Liu RM. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal. 2008;10:303\u2013319.", "ArticleIdList": ["PMC3686819", "17979497"]}, {"Citation": "Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, Forman HJ, Thannickal VJ, Postlethwait EM. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem. 2010;285:16239\u201316247.", "ArticleIdList": ["PMC2871491", "20228065"]}, {"Citation": "Long L, Crosby A, Yang X, Southwood M, Upton PD, Kim D-K, Morrell NW. Altered Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease. Circulation. 2009;119:566\u2013576.", "ArticleIdList": ["19153267"]}, {"Citation": "Parks WC, Roby JD. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part IV: Effects on expression of extracellular matrix genes. Res Rep Health Eff Inst. 1994:3\u201320. discussion 21\u201329.", "ArticleIdList": ["7840908"]}, {"Citation": "Pickrell JA, Hahn FF, Rebar AH, Horoda RA, Henderson RF. Changes in collagen metabolism and proteinolysis after repeated inhalation exposure to ozone. Exp Mol Pathol. 1987;46:159\u2013167.", "ArticleIdList": ["3030798"]}, {"Citation": "Reiser KM, Tyler WS, Hennessy SM, Dominguez JJ, Last JA. Long-term consequences of exposure to ozone. II. Structural alterations in lung collagen of monkeys. Toxicol Appl Pharmacol. 1987;89:314\u2013322.", "ArticleIdList": ["3603563"]}, {"Citation": "Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, Willich N, Rube C. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys. 2000;47:1033\u20131042.", "ArticleIdList": ["10863076"]}, {"Citation": "Saito K, Ishizaka N, Aizawa T, Sata M, Iso-o N, Noiri E, Mori I, Ohno M, Nagai R. Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. Am J Physiol Heart Circ Physiol. 2005;288:H1836\u20131843.", "ArticleIdList": ["15550525"]}, {"Citation": "Shima M, Adachi M. Changes of procoagulant and fibrinolytic activities in the alveoli of rats exposed to ozone. Nippon Eiseigaku Zasshi. 1991;46:724\u2013733.", "ArticleIdList": ["1890780"]}, {"Citation": "Shvedova AA, Kisin ER, Murray AR, Kommineni C, Castranova V, Fadeel B, Kagan VE. Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol Appl Pharmacol. 2008;231:235\u2013240.", "ArticleIdList": ["18534653"]}, {"Citation": "Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100:768\u2013776.", "ArticleIdList": ["PMC508247", "9259574"]}, {"Citation": "Stockstill BL, Chang LY, Menache MG, Mellick PW, Mercer RR, Crapo JD. Bronchiolarized metaplasia and interstitial fibrosis in rat lungs chronically exposed to high ambient levels of ozone. Toxicol Appl Pharmacol. 1995;134:251\u2013263.", "ArticleIdList": ["7570602"]}, {"Citation": "Sullivan DE, Ferris M, Pociask D, Brody AR. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol. 2008;5:145\u2013149.", "ArticleIdList": ["18569384"]}, {"Citation": "Sun JD, Pickrell JA, Harkema JR, McLaughlin SI, Hahn FF, Henderson RF. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis. Exp Mol Pathol. 1988;49:254\u2013266.", "ArticleIdList": ["2901982"]}, {"Citation": "Tzortzaki EG, Antoniou KM, Zervo MI, Lambiri I, Koutsopoulos A, Tzanakis N, Plataki M, Maltezakis G, Bouros D, Siafakas NM. Effects of antifibrotic agents on TGF-[beta]1, CTGF and IFN-[gamma] expression in patients with idiopathic pulmonary fibrosis. Respiratory Medicine. 2007;101:1821\u20131829.", "ArticleIdList": ["17391951"]}, {"Citation": "Valacchi G, Bocci V. Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets. Mediators Inflamm. 1999;8:205\u2013209.", "ArticleIdList": ["PMC1781810", "10704074"]}, {"Citation": "van Bree L, Dormans JA, Boere AJ, Rombout PJ. Time study on development and repair of lung injury following ozone exposure in rats. Inhal Toxicol. 2001;13:703\u2013718.", "ArticleIdList": ["11498802"]}, {"Citation": "Vayalil PK, Iles KE, Choi J, Yi A-K, Postlethwait EM, Liu R-M. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1281\u20131292.", "ArticleIdList": ["PMC3686828", "17890327"]}, {"Citation": "Vayalil PK, Olman M, Murphy-Ullrich JE, Postlethwait EM, Liu RM. Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen. Am J Physiol Lung Cell Mol Physiol. 2005;289:L937\u2013945.", "ArticleIdList": ["16258002"]}, {"Citation": "Vicencio AG, Lee CG, Cho SJ, Eickelberg O, Chuu Y, Haddad GG, Elias JA. Conditional overexpression of bioactive transforming growth factor-beta1 in neonatal mouse lung: a new model for bronchopulmonary dysplasia? Am J Respir Cell Mol Biol. 2004;31:650\u2013656.", "ArticleIdList": ["15333328"]}, {"Citation": "Williams AO, Flanders KC, Saffiotti U. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am J Pathol. 1993;142:1831\u20131840.", "ArticleIdList": ["PMC1887001", "8389528"]}, {"Citation": "Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281\u2013284.", "ArticleIdList": ["2374594"]}, {"Citation": "Zhao W, Zhao T, Chen Y, Ahokas RA, Sun Y. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem. 2008;317:43\u201350. Inhalation Toxicology Downloaded from informahealthcare.com by University Of Alabama Birmingham on 06/21/11 For personal use only.", "ArticleIdList": ["18581202"]}]}], "History": [{"Year": "2011", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "6", "Day": "24"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21689010", "NIHMS468198", "PMC3690533", "10.3109/08958378.2011.584919"]}}], "PubmedBookArticle": []}